Verified factor-similar pair

COWG vs SEIM

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

UMD
Similarity score
81
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • SEIM has the higher backtested relative Sharpe (1.469 vs 1.243).
  • SEIM has the lower published fee (0.15% vs 0.49%).
  • COWG is cheaper on dividend valuation (97 vs 119, where 100 is each fund's historical median).
  • SEIM has the stronger regression fit (adjusted R-squared 0.921 vs 0.759).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

COWG

Pacer US Large Cap Cash Cows Growth Leaders ETF
UMD
Adj. R2
0.759
Rel. Sharpe
1.243
Mkt beta
0.93
AUM
US$2.1B
MER
0.49%
Valuation
97

SEIM

SEI Enhanced U.S. Large Cap Momentum Factor ETF
UMD
Adj. R2
0.921
Rel. Sharpe
1.469
Mkt beta
1.09
AUM
US$1.3B
MER
0.15%
Valuation
119

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
COWG
+0.10
|t|
+0.6
SEIM
+0.07
|t|
+0.8
diff +0.03
HML
COWG
-0.10
|t|
-0.6
SEIM
-0.15
|t|
-1.5
diff +0.05
RMW
COWG
-0.18
|t|
-1.2
SEIM
-0.10
|t|
-1.1
diff -0.09
CMA
COWG
+0.11
|t|
+0.5
SEIM
+0.21
|t|
+1.9
diff -0.10
UMD
COWG
+0.19
|t|
+2.0
SEIM
+0.28
|t|
+4.7
diff -0.09

Why This Pair Matches

Exposure level
80
Exposure shape
95
Mkt beta diff
0.16
Rel. Sharpe diff
0.226

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

COWG fund page SEIM fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.